Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543153 · ClinicalTrials.gov registry record
The Exceptional Patient in Cancer Care
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 13
- Enrollment target
NCT00543153: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00543153 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00543153 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state. The primary aim of the study is to develop a detailed description of patients' experience of an exceptional disease course. The secondary aim is to define the content domain for assessment and measurement of exceptional disease course in patients with cancer and identify lessons learned from these exceptional patients that can be a base for future studies to benefit others.
Interventions
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
What the finished NCT00543153 record still lists
NCT00543153 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interview is the first listed.
NCT00543153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00543153 about?
NCT00543153 is a clinical study titled "The Exceptional Patient in Cancer Care". The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state. The primary aim of the...
What is the current status of trial NCT00543153?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2007-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00543153?
The interventions under investigation include: Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00543153?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia